Growth-hormone-releasing peptide 6 (GHRP6) prevents oxidant cytotoxicity and reduces myocardial necrosis in a model of acute myocardial infarction

Clinical Science

Volumn 112, Issue 3-4, 2007, Pages 241-250

  Berlanga, Jorge ^a   Cibrian, Danay ^a   Guevara, Luis ^b   Dominguez, Heberto ^c   Alba, Jose S ^a   Seralena, Alina ^a   Guillén, Gerardo ^a   López Mola, Ernesto ^a   López Saura, Pedro ^a   Rodriguez, Alberto ^d   Perez, Brumny ^a   Garcia, Diana ^a   Vispo, Nelson S ^a  

^a CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

^b HOSPITAL CLINICOQUIRÚRGICO HERMANOS AMEIJEIRAS   (Cuba)

^c Swine Research Institute   (Cuba)

^d Ctrl Institute for Digital Research   (Cuba)

Author keywords

Cardioprotection; Growth hormone releasing peptide 6 (GHRP6); Infarction; Ischaemia; Myocardium; Necrosis; Oxidative stress

Indexed keywords

C REACTIVE PROTEIN; CREATINE KINASE; HISTIDYL DEXTRO TRYPTOPHYLALANYLTRYPTOPHYL DEXTRO PHENYLALANYLLYSINAMIDE; INSULIN GROWTH FACTOR 1; SOMATOMEDIN; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; FEMALE; HEART MUSCLE NECROSIS; HORMONE RELEASE; IN VIVO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SWINE;

ANIMALS; ANTIOXIDANTS; ARRHYTHMIA; C-REACTIVE PROTEIN; CARDIOTONIC AGENTS; CELL SURVIVAL; CREATINE KINASE, MB FORM; DISEASE MODELS, ANIMAL; ELECTROCARDIOGRAPHY; FEMALE; INSULIN-LIKE GROWTH FACTOR I; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; NECROSIS; OLIGOPEPTIDES; ORGAN SIZE; OXIDATION-REDUCTION; OXIDATIVE STRESS; SWINE;

EID: 33847005870     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20060103     Document Type: Article

References (27)

1. Kostur, M. R. and Degeare, V. S. (2002) Interventional procedures in acute myocardial infarction. Minerva Cardioangiol. 50, 621-636
2. Murriel, C. L. and Mochly-Rosen, D. (2003) Opposing roles of delta and epsilon PKC in cardiac ischemia and reperfusion: targeting the apoptotic machinery. Arch. Biochem. Biophys. 420, 246-254
3. Smith, R. G., Palyha, O. C., Feighner, S. D. et al. (1999) Growth hormone releasing substances: types and their receptors. Horm. Res. 51, 1-8
4. Colonna, V. D. G., Rossoni, G., Bernareggi, M., Muller, E. E. and Berti, F. (1997) Cardiac ischemia and impairment of vascular endothelium function in hearts from growth-deficient rats: protection by hexarelin. Eur. J. Pharmacol. 334, 201-207
5. Berti, F., Muller, E., De Gennaro Colonna, V. and Rossoni, G. (1998) Hexarelin exhibits protective activity against cardiac ischemia in hearts from growth hormone-deficient rats. Growth Hormone IGF Res. 8, 149-152
6. Filigheddu, N., Fubini, A., Baldanzi, G. et al. (2001) Hexarelin protects H9c2 cardiomyocytes from doxorubicin-induced cell death. Endocrine 14, 113-119
7. Broglio, F., Guarracino, F., Benso, A. et al. (2002) Effects of acute hexarelin administration on cardiac performance in patients with coronary artery disease during by-pass surgery. Eur. J. Pharmacol. 448, 193-200
8. Broglio, F., Benso, A., Valetto, M. R. et al. (2001) Growth hormone-independent cardiotropic activities of growth hormone-releasing peptides in normal subjects, in patients with growth hormone deficiency, and in patients with idiopathic or ischemic dilated cardiomyopathy. Endocrine 14, 105-108
9. Iwase, M., Kanazawa, H., Kato, Y. et al. (2004) Growth hormone-releasing peptide can improve left ventricular dysfunction and attenuate dilation in dilated cardiomyopathic hamsters. Cardiovasc. Res. 61, 30-38
10. Shen, Y. T., Lynch, J. J., Hargreaves, R. J., Gould, R. J. et al. (2003) A growth hormone secretagogue prevents ischemic-induced mortality independently of the growth hormone pathway in dogs with chronic dilated cardiomyopathy. J. Pharmacol. Exp. Ther. 306, 815-820
11. Cibrian, D., Ajamieh, H., Berlanga, J. et al. (2006) Use of growth-hormone-releasing peptide-6 (GHRP-6) for the prevention of multiple organ failure. Clin. Sci. 110, 563-573
12. Moon, C., Krawczyk, M., Ahn, D. et al. (2003) Erythropoietin reduces myocardial infarction and left ventricular functional decline after coronary artery ligation in rats. Proc. Natl. Acad. Sci. U.S.A. 100, 11612-11617
13. Vivaldi, M. T., Kloner, R. A. and Schoen, F. J. (1985) Triphenyltetrazolium staining of irreversible ischemic injury following coronary artery occlusion in rats. Am. J. Pathol. 121, 522-530
14. Keesey, J. (1987) Enzymes for routine quantitative analysis. Biochemica Information: a Revised Biochemical Reference Source, pp. 80-81, Boehringer Mannheim, Berlin
15. Keesey, J. (1987) Enzymes for routine quantitative analysis. Biochemica Information: a Revised Biochemical Reference Source, pp. 15-16, Boehringer Mannheim, Berlin
16. van de Bos, E. J., Mess., B.M.E., de Ward, M.C., de Crom, R. and Duncker, D. J. (2005) A novel model of cryoinjury-induced myocardial infarction in the mouse: a comparison with coronary artery ligation. Am. J. Physiol. Heart Circ. Physiol. 289, H1291-H1300
17. Marczin, N., El-Habashi, E., Hoare, S. G., Bundy, R. and Yacoub, M. (2003) Antioxidants in myocardial ischemia-reperfusion injury: therapeutic potential and basic mechanisms. Arch. Biochem. Biophys. 420, 222-236
18. Sadek, H., Nulton-Persson, A., Szweda, P. and Szweda, L. (2003) Cardiac ischemia/reperfusion, aging, and redox-dependent alterations in mitochondrial function. Arch. Biochem. Biophys. 420, 201-208
19. Southorn, P. A. and Powis, G. (1988) Free radicals in medicine. I. Chemical nature and biologic reactions. Mayo Clin. Proc. 63, 381-389
20. Marklund, S. L. (1984) Properties of extracellular superoxide dismutase from human lung. Biochem. J. 220, 269-272
21. Iwakura, A., Fujita, M., Hasegawa, K. et al. (2001) Pericardial fluid from patients with ischemic heart disease induces myocardial cell apoptosis via an oxidant stress-sensitive p38 mitogen-activated protein kinase pathway. J. Mol. Cell. Cardiol. 33, 419-430
22. Linke, A., Müller, P., Nurzynska, D. et al. (2005) Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc. Natl. Acad. Sci. U.S.A. 102, 8966-8971
23. Frago, L. M., Paneda, C., Argente, J. and Chowen, J. A. (2005) Growth hormone-releasing peptide-6 increases insulin-like growth factor-I mRNA levels and activates Akt in RCA-6 cells as a model of neuropeptide Y neurons. J. Neuroendocrinol. 17, 701-710
24. Baldanzi, G., Filigheddu, N., Cutrupi, S. et al. (2002) Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI3-kinase/Akt. J. Cell. Biol. 159, 1029-1037
25. Lucchesi, P. A. (2004) Growth hormone-releasing peptides and the heart: secretagogues or cardioprotectors? Cardiovasc. Res. 61, 7-8
26. VanderWeele, D. J., Zhou, R. and Rudin, C. M. (2004) Akt up-regulation increases resistance to microtubule-directed chemotherapeutic agents through mammalian target of rapamycin. Mol. Cancer Ther. 3, 1605-1613
27. Huisamen, B., Genade, S. and Lochner, A. (2004) Glucagon-like peptide-1 (GLP-1) protects the heart against ischaemia by activating glycoclysis. Cardiovasc. J. S. Afr. 15, S15-S20